<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000597162"><TermName>obatoclax mesylate</TermName><TermPronunciation>(oh-BA-toh-klax MEH-zih-layt)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of several types of cancer. It is a form of obatoclax, which blocks the activity of certain proteins needed for cells to live and may cause tumor cells to die. It is a type of apoptosis inducer.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000720961" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;obatoclax mesylate&quot;" language="en" id="_3"/><MediaLink ref="CDR0000720960" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;mesilato de obatoclax&quot;" language="es" id="_4"/><SpanishTermName>mesilato de obatoclax</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de varios tipos de cáncer. Es una forma de obatoclax que bloquea la actividad de ciertas proteínas que las células necesitan para vivir y que puede destruir las células cancerosas. Es un tipo de inductor de la citoptosis.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2008-05-30</DateFirstPublished></GlossaryTerm>
